Class Action And SaaS Shift Stumbles Might Change The Case For Investing In Varonis Systems (VRNS)

• In the past year, Varonis Systems faced a class action lawsuit alleging it misled investors about its ability to convert existing customers, following disappointing Q3 2025 results, guidance cuts, the end-of-life of its self-hosted solution, and a 5% workforce reduction.
• These combined legal and operational setbacks spotlight how execution risks in Varonis’ SaaS transition and product roadmap may weigh on confidence in its data security platform.
• We’ll now examine how the lawsuit and the discontinuation of the self-hosted product reshape Varonis Systems’ existing investment narrative.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Varonis Systems Investment Narrative Recap

To own Varonis Systems, you need to believe its data security platform and SaaS-first model can translate growing demand into durable, recurring software revenues despite current losses. The class action lawsuit and abrupt stock drop highlight execution risk in its SaaS transition, and in the near term the biggest swing factor is whether SaaS ARR growth remains intact while the largest risk is that customer churn and lower conversion from self hosted offerings undermine that growth path.

Among recent announcements, the decision to end of life the self hosted solution by December 2026 ties most directly to the lawsuit’s focus on conversion and renewal risk. This move concentrates Varonis even more on its SaaS platform, which is central to the growth story, but it also raises questions about how many on premises customers will migrate versus churn, and how that will feed through to ARR, margins and investor confidence in the coming quarters.

Yet, beneath the SaaS growth story, investors should also be aware of the possibility that legacy on premises renewals weaken further and...

Read the full narrative on Varonis Systems (it's free!)

Varonis Systems’ narrative projects $911.4 million revenue and $119.3 million earnings by 2028.

Uncover how Varonis Systems' forecasts yield a $33.90 fair value, a 37% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming revenue could grow about 18.5% annually to roughly US$1.0 billion, but the lawsuit and self hosted sunset could challenge those expectations and the bullish view that Database Activity Monitoring and Interceptor would unlock smooth upsell, so it is worth comparing these scenarios before deciding where you sit on that spectrum.

Explore 3 other fair value estimates on Varonis Systems - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Varonis Systems research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Varonis Systems research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Varonis Systems' overall financial health at a glance.

Want Some Alternatives?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Find 48 companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com